Deciphering the regulatory principles governing enhancer specificity
Deciphering the regulatory principles governing enhancer specificity
批准号:
9351144
负责人:
Emma Kirsten Farley
金额:
$232.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2022-05-31
关键词:
Alpha CellBindingBiochemicalBiological AssayChordataCiona intestinalisCodeComplementDNADefectDevelopmentDiseaseElementsEmbryoEnhancersGene ExpressionGene Expression RegulationGenesGenetic CodeGenomeGenomicsGenotypeHereditary DiseaseIndividualInstructionKnowledgeLeadLifeMethodologyMusMutationPhenotypePopulationProteinsRegenerative MedicineReporterSpecificitySystemTissue-Specific Gene ExpressionTissuesVariantWorkdisease-causing mutationexperimental studygenomic datainsightloss of functionnovel therapeuticspublic health relevancescaffoldsynthetic biologytissue culturetooltranscription factor
中文摘要
摘要
英文摘要
Abstract
Enhancers are the genomic elements that encode the instructions for when and where genes are
expressed during development. The majority of mutations leading to disease are thought to reside in
enhancers. However, we do not understand which changes in enhancer sequence are inert sequence
variations between individuals or populations and which impact gene regulation and cellular integrity.
These fundamental questions remain unsolved, because we cannot relate enhancer sequence to gene
expression and phenotype. This gap in our knowledge is stalling our ability to interpret genomic data
and understand development, cellular integrity, and diseases. Enhancer sequences provide a scaffold for
transcription factors to bind to, by recognizing specific signatures in the DNA. The physical constraints
that govern how these proteins interact with enhancer DNA could lead to a set of grammatical
constraints that can be used to understand the relationship between enhancer sequence and tissue
specific gene expression. I propose the development of a toolkit of methodologies and approaches to
decipher the grammatical constraints on tissue specific enhancer activity. I will use highly parallel
functional reporter assays, high-throughput genotype to phenotype studies along with biochemical
assays, synthetic biology, and loss of function strategies. These experiments will be carried out in the
chordate Ciona intestinalis, as it is a unique system in which millions of enhancer variants can be
assayed for function in all cells of a developing embryo. Work in Ciona will be complemented with
experiments in chick, mouse and tissue culture to directly inform vertebrate development and pinpoint
mutations causing disease. Determining the ‘genetic code’ that relates the coding sequences of genes
into protein has provided detailed insight into a major component of our genome. Once we have a
similar code to decipher the instructions for when and where these genes are expressed, we will have
powerful tools to understand how the genome encodes the instructions for building and maintaining
life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the regulatory principles governing enhancer specificity
-
批准号:10319729
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2021
-
负责人:Emma Kirsten Farley
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: